Autoantibodies Specific to ERα are Involved in Tamoxifen Resistance in Hormone Receptor Positive Breast Cancer

Tamoxifen resistance is a major hurdle in the treatment of estrogen receptor (ER)-positive breast cancer. The mechanisms of tamoxifen resistance are not fully understood although several underlying molecular events have been suggested. Recently, we identified autoantibodies reacting with membrane-as...

Descripción completa

Detalles Bibliográficos
Autores principales: Maselli, Angela, Parlato, Stefania, Puglisi, Rossella, Raggi, Carla, Spada, Massimo, Macchia, Daniele, Pontecorvi, Giada, Iessi, Elisabetta, Pagano, Maria Teresa, Cirulli, Francesca, Gabriele, Lucia, Carè, Alessandra, Vici, Patrizia, Pizzuti, Laura, Barba, Maddalena, Matarrese, Paola, Pierdominici, Marina, Ortona, Elena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6678306/
https://www.ncbi.nlm.nih.gov/pubmed/31331091
http://dx.doi.org/10.3390/cells8070750

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6678306/
https://www.ncbi.nlm.nih.gov/pubmed/31331091
http://dx.doi.org/10.3390/cells8070750

Ejemplares similares